Stay updated on Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s displayed software revision/version was updated from **v3.5.2** to **v3.5.3**. This indicates a general site release with no apparent change to the trial’s study details.SummaryDifference0.0%

- Check20 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedAdministrative updates to the page metadata (revision v3.5.0 and EU trial identifier 2018-000096-32) were applied. There were no changes to the study details, eligibility criteria, or outcomes.SummaryDifference0.3%

- Check56 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 across the site.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision: v3.4.2 is shown, replacing v3.4.1, and the government funding notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange DetectedAdditions include a government funding status notice and the new Revision: v3.4.1, while the previous Revision: v3.4.0 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.